Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-06ALNY144McLaughlin Melissa plan to sell securities of ALNYLAM PHARMACEUTICALS, INC. under Form 144MEDIUM
McLaughlin Melissa filed Form 144 to notify SEC of plan to sell 2286 units of ALNYLAM PHARMACEUTICALS, INC. securities around 2026-04-06, with aggregate market value of $731,748.60. The total outstanding units is 132623144.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mega CapBiotechnology
2026-04-06NUVB144KERRY WENTWORTH plan to sell securities of NUVATION BIO INC. under Form 144MEDIUM
KERRY WENTWORTH filed Form 144 to notify SEC of plan to sell 200000 units of NUVATION BIO INC. securities around 2026-04-06, with aggregate market value of $882,000.00. The total outstanding units is 346597289.0. The amount planned to be sold represents 0.06% of total outstanding units; ...
Small CapBiotechnology